SciencePower, a next-generation postbiotic platform company, today announced that it has entered into a license agreement with Mayo Clinic. The agreement enables collaborative research led by Mayo Clinic investigators to explore the potential of SciencePower’s proprietary postbiotic compositions in breast cancer biology. The collaboration will focus on understanding how specific microbiome-derived compositions influence immune and cellular pathways relevant to breast cancer. Early preclinical ...

Kioxia Corporation today announced the development of an AI-driven image recognition technology that automatically identifies products moving through logistics workflows collaborating with Tsubakimoto Chain Co. (Tsubakimoto Chain) and EAGLYS Inc. (EAGLYS). This system supports advanced automation and efficiency in logistics, enabling organizations to respond quickly to changing market needs while managing costs and maintaining service quality. KIOXIA AiSAQ™1 and Memory-Centric AI2 technologies ...